Search

#ProductLiability
R
Reuters @reuters.com Β· London πŸ‡¬πŸ‡§ Β· 2d

The California Supreme Court is set to hear a case regarding whether drug manufacturers, such as Gilead Sciences, have a legal obligation to develop allegedly safer alternatives to their existing medications, which could significantly impact product liability law and the pharmaceutical industry's approach to innovation. #ProductLiability #Innovation #Healthcare #US

www.reuters.com
California's highest court to consider whether drugmakers have 'duty to innovate'
May 6 (Reuters) - The California Supreme Court will on Wednesday consider whether manufacturers of drugs that are considered safe are legally obligated to continue developing drugs that are allegedly safer.
R
Reuters @reuters.com Β· London πŸ‡¬πŸ‡§ Β· 2d

The California Supreme Court is set to review whether drug manufacturers like Gilead Sciences have a legal obligation to continue developing allegedly safer alternatives for their products, following a case where 24,000 HIV patients claim Gilead neglected to pursue a newer drug with fewer side effects in favor of maximizing profits from an existing medication. #PharmaceuticalIndustry #ProductLiability #Innovation #US

www.reuters.com
California's highest court to consider whether drugmakers have 'duty to innovate'
May 6 (Reuters) - The California Supreme Court will on Wednesday consider whether manufacturers of drugs that are considered safe are legally obligated to continue developing drugs that are allegedly safer.
R
Reuters @reuters.com Β· London πŸ‡¬πŸ‡§ Β· 2d

The California Supreme Court will review a case involving Gilead Sciences, which is appealing lower court decisions allowing HIV patients to pursue negligence claims over the company's halt in developing a potentially safer alternative drug, a ruling that could reshape product liability law and impose a "duty to innovate" on drug manufacturers. #Pharmaceuticals #Innovation #ProductLiability #US

www.reuters.com
California's highest court to consider whether drugmakers have 'duty to innovate'
May 6 (Reuters) - The California Supreme Court will on Wednesday consider whether manufacturers of drugs that are considered safe are legally obligated to continue developing drugs that are allegedly safer.
R
Reuters @reuters.com Β· London πŸ‡¬πŸ‡§ Β· 2d

The California Supreme Court is set to review whether drug manufacturers, such as Gilead Sciences, are legally required to continue developing allegedly safer alternatives to their existing drugs, following a negligence claim from approximately 24,000 HIV patients regarding Gilead's decision to cease development of a new drug with fewer side effects. #Pharmaceuticals #ProductLiability #Innovation #US

www.reuters.com
California's highest court to consider whether drugmakers have 'duty to innovate'
May 6 (Reuters) - The California Supreme Court will on Wednesday consider whether manufacturers of drugs that are considered safe are legally obligated to continue developing drugs that are allegedly safer.